Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dengue Fever Immunology
Reports by N.K. Tripathi and co-researchers describe recent advances in dengue fever immunology
June 11th, 2008
Fresh data on dengue fever are presented in the report 'Production and characterization of recombinant dengue virus type 4 envelope domain III protein.' "Dengue fever, a mosquito-borne viral disease has become a major worldwide public health problem with a dramatic expansion in recent years. Cultivation process for production of recombinant dengue virus type 4 envelope domain III (rDen 4 EDIII) protein in Escherichia coli was developed for its diagnostic use as well as for further studies in immunoprophylaxis," scientists in Gwalior, India report. "The dissolved oxygen level was maintained at 20-30% of air saturation. The culture was induced with 1mM of isopropyl...
Source: Vaccine Weekly (2008-06-11)
|
